December 31, 2018
Fund manager: China Resources Yuanta Fund Management Co., Ltd.
Fund custodian: Agricultural Bank of China Co., Ltd.
Submission date: March 27, 2019
§1 Important tips and contents
1.1 Important The board of directors and directors of
Fund Manager guarantee that there are no false records, misleading statements or major omissions in the information contained in this report, and bear individual and joint legal liability for the authenticity, accuracy and completeness of its content. This annual report has been signed and approved by more than two-thirds of the independent directors and is issued by the chairman of the board. The Agricultural Bank of China Co., Ltd., the custodian of the
fund, reviewed the financial indicators, net worth performance, profit distribution, financial accounting reports, investment portfolio reports and other contents in this report on March 25, 2019, in accordance with the provisions of the fund contract, and ensured that There are no false records, misleading statements or major omissions in the review content. The
fund manager promises to manage and use the fund assets in accordance with the principles of honesty, credibility, diligence and responsibility, but does not guarantee that the fund will be profitable. The past performance of the
Fund is not indicative of its future performance. Investment involves risks, and investors should carefully read the fund's prospectus and its updates before making investment decisions.
The financial information in this report has been audited. Ernst & Young Hua Ming LLP (Special General Partnership) has issued a standard unqualified audit report for the Fund. Investors are advised to read it carefully.
This reporting period starts from January 1, 2018 and ends on December 31, 2018.
The summary of this annual report is extracted from the text of the annual report. Investors who want to know more details should read the text of the annual report.
§2 Fund introduction
2.1 Fund basic information
2.2 Fund product description
2.3 Fund manager and fund custodian
2.4 Information disclosure method
§3 Main financial indicators, fund net value performance and profit distribution
3.1 Main accounting data and financial indicators
Amount unit: RMB
Note: 1. Realized income for the current period refers to the balance of the fund’s interest income, investment income, and other income (excluding income from changes in fair value) for the current period after deducting relevant expenses. Profit for the period is the realized income for the period plus gains from changes in fair value for the period.
2. The fund performance indicators mentioned do not include various fees for holders to subscribe or trade funds (for example, subscription and redemption fees for open-end funds, fund conversion fees, etc.), and the actual income level after including fees is lower than listed number.
3.2 Fund net value performance
3.2.1 Fund share net value growth rate and its comparison with the performance of the same period Comparison of benchmark yield
3.2.2 Changes in the cumulative net value growth rate of the fund share since the fund contract came into effect and its benchmark return comparison with the performance of the same period Comparison of rate changes
3.2.3 Comparison of the annual net value growth rate of the fund since the fund contract came into effect and its benchmark rate of return with performance over the same period
Note: The effective date of the fund contract is August 18, 2014. In the figure, the Fund's net value growth rate and performance benchmark return rate in 2014 are calculated based on the actual duration of the year (August 18, 2014 to December 31, 2014).
3.3 Profit distribution of the Fund in the past three years
As of the end of this reporting period, the Fund has not distributed profits.
§4 Manager’s report
4.1 Fund manager and fund manager’s situation
4.1.1 Fund manager and his experience in managing funds
China Resources Yuanta Fund Management Co., Ltd. was approved by China Securities Regulatory Commission [2012] No. 1746 , completed industrial and commercial registration on January 17, 2013, headquartered in Shenzhen, with a registered capital of 300 million yuan. The company was jointly established by China Resources Shenzhen Investment Trust Co., Ltd. and Taiwan Yuanta Securities Investment Trust Co., Ltd., holding 51% and 49% of the shares respectively.
As of December 31, 2018, this fund manager managed a total of eleven open-end funds: China Resources Yuanta Anxin Flexible Allocation Hybrid Securities Investment Fund, China Resources Yuanta Cash Income Money Market Fund, and China Resources Yuanta Information Media Technology Hybrid Securities investment fund, China Resources Yuanta Healthcare Quantitative Hybrid Securities Investment Fund, China Resources Yuanta FTSE China A50 Index Securities Investment Fund, China Resources Yuanta Stable Income Bond Securities Investment Fund, China Resources Yuanta Zhongchuang 100 Trading Open-end Index Securities Investment Fund Feeder Fund, China Resources Yuanta Cash Connect Money Market Fund, China Resources Yuanta Runxin Bond Securities Investment Fund, China Resources Yuanta Runtai Shuangxin Bond Securities Investment Fund, China Resources Yuanta Runze Bond Securities Investment Fund.
4.1.2 Introduction to the Fund Manager (or Fund Manager Group) and Fund Manager Assistant
Note: ① The above-mentioned appointment and resignation dates are filled in based on the appointment and dismissal dates disclosed by the fund manager.
② The meaning of securities practice complies with the relevant provisions of the "Measures for the Administration of Qualifications of Securities Practitioners" of the industry association.
③The fund manager Shi Wubin officially resigned on February 20, 2019 and no longer serves as the fund manager. For details, please refer to the "Announcement of China Resources Yuanta Fund Management Co., Ltd. on the Change of Fund Manager of China Resources Yuanta Healthcare Quantitative Hybrid Securities Investment Fund" released on February 21, 2019.
4.2 Manager’s explanation of compliance with regulations and trustworthiness of the Fund’s operations during the reporting period
During this reporting period, the Fund Manager strictly complied with the Securities Investment Fund Law of the People’s Republic of China and its various implementation rules, the Fund’s The fund assets shall be managed and used in accordance with the provisions of contracts and other relevant laws and regulations, in line with the principles of good faith, diligence, trust in the market and society, and in order to seek the best interests of fund holders. During the reporting period, the fund investment management complied with relevant laws and regulations and fund contracts, and there was no behavior that harmed the interests of fund holders.
4.3 Manager’s special explanation on fair transactions during the reporting period
4.3.1 Fair transaction system and control methods
According to the "Securities Investment Fund Law of the People's Republic of China", "Securities Investment Fund Operation Management Measures" and "Securities Investment Fund Management" In accordance with the "Guiding Opinions on the Company's Fair Trading System" and other laws and regulations, the company has formulated the "Fair Trading Management Measures of China Resources Yuanta Fund Management Co., Ltd." to regulate the internal control of investment decisions, internal control of research, internal control of transaction execution, and the implementation of fair trade. Effectiveness evaluation, supervision and auditing, information disclosure and reporting are stipulated to ensure that the different investment portfolios managed by the company are treated fairly and to protect the legitimate rights and interests of investors. The company implements a centralized trading system for all investment products and strictly follows the fair trading principles of time priority and price priority. At the same time, it monitors abnormal trading behaviors that may lead to unfair transactions and transfer of interests, and monitors the transaction price difference between different investment portfolios in the same direction. Conduct analysis to prevent benefit transfer from occurring.
4.3.2 Implementation of the fair trading system
During this reporting period, the fund manager strictly abided by laws, regulations and the company's internal systems on fair trading, treated different investment portfolios fairly in investment management activities, and the implementation of the fair trading system was good. , no violation of the fair trade system occurred.
During this reporting period, the fund manager analyzed the price differences of same-direction transactions between different investment portfolios under its management during four consecutive quarters and under different time windows (intraday, within 3 days, and within 5 days). The analysis results show that The same-direction transactions of its portfolios are normal, and the price differences are within the range that can be reasonably explained.
4.3.3 Special explanation of abnormal trading behavior
During this reporting period, no abnormal trading behavior was found in the Fund. In all investment portfolios managed by the fund manager, there is no situation in which the unilateral trading volume of a small reverse transaction on the same day in the public auction of the participating exchanges exceeds 5% of the trading volume of the security on that day.
4.4 Manager’s explanation of the fund’s investment strategy and performance during the reporting period
4.4.1 Analysis of the fund’s investment strategy and operation during the reporting period
In the 2018 A-share bear market, all industries fell, with the CSI Pharmaceutical Index falling 25.97%.During the reporting period, the Fund used quantitative stock selection strategies to invest mainly in high-quality value growth stocks with good performance and reasonable valuations in the pharmaceutical industry.
4.4.2 Fund performance during the reporting period
During the reporting period, the fund's net return rate was -27.90%, and the benchmark return rate for the same period was -20.19%.
4.5 Manager’s brief outlook on macroeconomic, securities market and industry trends
Economic growth slowed down in 2018, and downward pressure will still be great in 2019. After the stock market crash in 2018, the current risk release is relatively sufficient, and the market valuation Overall cheaper. The negative policies of the pharmaceutical industry have basically been released, and the industry growth rate is relatively stable. During the economic downturn, defensive industries with stable profits such as pharmaceuticals may achieve excess returns.
4.6 The manager’s internal supervision and audit work on the fund
During this reporting period, the fund manager insisted on standardizing operations, preventing risks, and protecting the interests of fund holders, and continued to comply with the overall requirements of the company’s internal control. Committed to improving the internal control mechanism, strengthening the control and prevention of internal risks, ensuring the implementation of various laws and regulations and management systems, and ensuring that the fund contract is strictly performed. In accordance with the prescribed authority and procedures,
company independently carries out compliance audits of fund operations and company management through real-time monitoring, on-site inspections, key spot checks and personnel inquiries, and promptly puts forward suggestions for improvement when problems are discovered and urges business departments to make rectifications. , and at the same time regularly issue supervision and audit reports to the board of directors and company management.
company adopts three-stage work including pre-prevention, in-process control and post-event supervision to strengthen the management and monitoring of daily investment operations to ensure that investments follow established investment decision-making procedures and business processes, and that all fund investments meet the requirements of proportional control. Strictly implement the hierarchical authorization system to ensure independent and fair fund investment.
The fund manager promises to adhere to the principles of good faith, diligence and responsibility in managing and using fund assets, continuously improve the scientific nature and effectiveness of internal supervision and audit work, strive to prevent various risks, and seek the best interests for fund holders.
4.7 Manager’s explanation of fund valuation procedures and other matters during the reporting period
According to the relevant regulations of the China Securities Regulatory Commission and the fund contract, the fund manager should strictly follow the new standards, the relevant regulations of the China Securities Regulatory Commission and the fund contract on valuation. According to the agreement, the investment types held by the fund will be valued. The custodian of this fund performs the review responsibilities of valuation and net worth calculation in accordance with the requirements of laws and regulations. When the valuation adjustment results in a change in the fund's net asset value of more than 0.25%, the accounting firm will issue an audit opinion and issue a report on the appropriateness of the relevant valuation models, assumptions and parameters used. Pricing service agencies provide pricing services in accordance with commercial contracts. Among them, in order to ensure the compliance of the valuation work, the fund manager has established a specialized agency responsible for the decision-making and execution of the valuation work. The members include the chief inspector, the person in charge of investment risk, the person in charge of securities research, and the person in charge of legal supervision. And the person in charge of fund accounting, etc. Members of this organization all have professional competencies and relevant professional qualifications, are proficient in theoretical knowledge in their respective fields, are familiar with relevant policies and regulations, and have rich practical experience. At the same time, according to the relevant systems formulated by fund management companies, fund managers are not included among the members of the valuation decision-making body. During the reporting period, there were no significant conflicts of interest among the parties involved in the valuation process.
4.8 Manager’s explanation of the fund’s profit distribution during the reporting period
The fund did not distribute profits during the reporting period, which complied with relevant laws and regulations and the provisions of the fund contract.
4.9 The manager’s explanation on the number of fund holders or the fund’s net asset value warning situation during the reporting period
During the reporting period, the fund’s net asset value has been below 50 million yuan for more than 60 consecutive working days. The fund manager has reported the fund’s solution to the China Securities Regulatory Commission. During this reporting period, there was no situation where the number of fund unit holders was less than 200 for 20 consecutive working days.
§5 Custodian Report
5.1 Statement on the Fund’s Custodian’s Compliance and Trustworthiness During the Reporting Period
In the process of custody of this Fund, the Fund’s Custodian, Agricultural Bank of China Co., Ltd., strictly abides by the relevant laws of the Securities Investment Fund Law In accordance with the provisions of regulations and the provisions of the fund contract and custody agreement, the fund manager of this fund, China Resources Yuanta Fund Management Co., Ltd., has conducted careful and independent accounting for the investment operations of the fund from January 1, 2018 to December 31, 2018. accounting and necessary investment supervision, conscientiously fulfilled the obligations of the custodian, and did not engage in any behavior that harmed the interests of fund share holders.
5.2 Custodian’s explanation of the Fund’s investment operations, compliance with laws and regulations, net value calculation, profit distribution, etc. during the reporting period
This Custodian believes that China Resources Yuanta Fund Management Co., Ltd.’s investment operations of the Fund and the Fund’s net asset value have There was no behavior that harmed the interests of fund share holders in terms of calculation, calculation of fund share subscription and redemption prices, fund expenses and profit distribution; during the reporting period, the Securities Investment Fund Law and other relevant laws were strictly complied with Regulations, all important aspects of operation are strictly in accordance with the provisions of the fund contract.
5.3 The custodian expresses its opinion on the authenticity, accuracy and completeness of the financial information and other contents in this annual report
The custodian believes that the information disclosure matters of China Resources Yuanta Fund Management Co., Ltd. comply with the "Regulations on the Administration of Information Disclosure of Securities Investment Funds" and other In accordance with the provisions of relevant laws and regulations, the financial indicators, net worth performance, income distribution, financial accounting reports, investment portfolio reports and other information in the annual report of the Fund prepared and disclosed by the Fund Manager are true, accurate and complete, and no damage to the Fund has been found. behavior in the interest of the holder.
§6 Audit report
6.1 Basic information of the audit report
6.2 Basic content of the audit report
§7 Annual financial statement
7.1 Balance sheet
Accounting entity : China Resources Yuanda Healthcare Quantitative Hybrid Securities Investment Fund
Report Deadline: December 31, 2018
Unit: RMB
Note: As of the report deadline, December 31, 2018, the net value of fund shares was 0.956 yuan, and the total number of fund shares was 27,195,128.72.
7.2 Income statement
Accounting entity: China Resources Yuanda Healthcare Quantitative Hybrid Securities Investment Fund
This reporting period: January 1, 2018 to December 31, 2018
Unit: RMB
7.3 Owner’s equity ( Fund Net Value) Statement of Changes
Accounting entity: China Resources Yuanda Healthcare Quantitative Hybrid Securities Investment Fund
This reporting period: January 1, 2018 to December 31, 2018
Unit: RMB
Statement notes are for financial statements. component.
The financial statements from 7.1 to 7.4 of this report are signed by the following persons in charge:
______Sun Yewei______ ______Huang Xiaofang______ ____Huang Xiaofang____
Fund manager person in charge of accounting work person in charge of accounting department person in charge
7.4 Statement notes
7. 4.1 Fund Basic Information
China Resources Yuanta Healthcare Quantitative Hybrid Securities Investment Fund (hereinafter referred to as the "Fund"), formerly known as China Resources Yuanta Healthcare Quantitative Equity Securities Investment Fund, was approved by the China Securities Regulatory Commission (hereinafter referred to as the "China Securities Regulatory Commission"). "Reply on the Approval of the Raising of China Resources Yuanta Healthcare Quantitative Equity Securities Investment Fund") Securities Regulatory Commission License [2014] No. 472, which was approved by China Resources Yuanta Fund Management Co., Ltd. in accordance with the "Securities Investment Fund Law of the People's Republic of China" and the " China Resources Yuanda Healthcare Quantitative Equity Securities Investment Fund Fund Contract" is responsible for the public offering. This fund is a contract-type open-end fund with an indefinite duration. The initial fundraising period is from July 9, 2014 to August 12, 2014. The initial fundraising does not include the interest on subscription funds, and a total of 406,738,268.41 yuan was raised. According to Ernst & Young Hua Ming Accounting Firm (Special general partnership) verifies and issues the Ernst & Young Hua Ming (2014) Capital Verification Report No. 61032987_H03.After filing with the China Securities Regulatory Commission, the "China Resources Yuanta Healthcare Quantitative Equity Securities Investment Fund Fund Contract" officially came into effect on August 18, 2014. The total number of fund shares on the effective date of the fund contract was 406,876,288.32 fund shares, including interest on subscription funds. Equivalent to 138,019.91 fund shares. The fund manager of this fund is China Resources Yuanta Fund Management Co., Ltd., and the fund custodian is Agricultural Bank of China Co., Ltd. (hereinafter referred to as "Agricultural Bank of China").
In accordance with the "Measures for the Operation and Management of Publicly Offered Securities Investment Funds", the "Regulations on Implementation Relevant Issues" and the relevant provisions of the fund contract, after consultation with the fund custodian and reporting to the China Securities Regulatory Commission for filing, the fund has been operating since August 2015 Starting from the 3rd, China Resources Yuanta Healthcare Quantitative Equity Securities Investment Fund was renamed as this fund.
According to the relevant provisions of the "Securities Investment Fund Law of the People's Republic of China" and the "China Resources Yuanda Healthcare Quantitative Hybrid Securities Investment Fund Fund Contract", the investment scope of this fund is financial instruments with good liquidity, including domestic public offerings in accordance with the law. Traded stocks (including small and medium-sized boards, GEM and other stocks approved by the China Securities Regulatory Commission for listing), bonds, money market instruments, warrants, stock index futures, bank deposits, asset-backed securities, etc., as well as fund investments permitted by laws and regulations or by the China Securities Regulatory Commission Other financial instruments (but must comply with relevant regulations of the China Securities Regulatory Commission). The investment portfolio ratio of this fund is: the fund's stock investment ratio ranges from 60% to 95% of the fund's assets. The fund's investment ratio in the stocks of listed companies in the medical industry is not less than 80% of the non-cash fund assets. Each trading day After deducting the trading margin required for the stock index futures contract, the investment proportion of cash or government bonds with a maturity date within one year shall not be less than 5% of the fund's net asset value. Cash does not include settlement reserves, deposits and deposits. Security deposit, subscription money receivable, etc.
The performance comparison benchmark of this fund is: CSI Medical and Health Index return rate × 80% + ChinaBond Composite Index return rate × 20%.
7.4.2 Basis for the preparation of accounting statements
The Fund's financial statements are in accordance with the " Accounting Standards for Business Enterprises -Basic Standards" promulgated by the Ministry of Finance and the subsequent specific accounting standards, application guidelines, interpretations and other relevant regulations promulgated and revised (below (collectively referred to as "Accounting Standards for Business Enterprises"). At the same time, in terms of specific accounting valuation calculations and information disclosure, we also refer to the "Guidelines for the Accounting Business of Securities Investment Funds" revised and issued by the Asset Management Association of China, and the "China Securities Regulatory Commission's Guidelines on Securities Investment" formulated by the China Securities Regulatory Commission. Guiding Opinions on Fund Valuation Business", "Measures for the Administration of Information Disclosure of Securities Investment Funds", "Guidance on the Content and Format of Information Disclosure of Securities Investment Funds" No. 2, "Content and Format of Annual Reports", "Compilation of Information Disclosure of Securities Investment Funds" Rules No. 3 "Preparation and Disclosure of Notes to Accounting Statements", "XBRL Template No. 3 for Information Disclosure of Securities Investment Funds" and other relevant regulations promulgated by the China Securities Regulatory Commission and the Asset Management Association of China.
These financial statements are presented on the basis of the Fund's going concern.
7.4.3 Statement on compliance with the Accounting Standards for Business Enterprises and other relevant regulations
This financial statement complies with the requirements of the Accounting Standards for Business Enterprises and truly and completely reflects the financial status of the Fund as of December 31, 2018 as well as the operating results and net worth of 2018. changes.
7.4.4 Explanation that the accounting policies and accounting estimates adopted in this reporting period are consistent with the most recent annual report
The accounting policies and accounting estimates adopted in this reporting period are consistent with the most recent annual report.
7.4.5 Description of changes in accounting policies and accounting estimates and error corrections
7.4.5.1 Description of changes in accounting policies
There are no significant changes in accounting policies that need to be explained by the Fund during the reporting period.
7.4.5.2 Explanation of changes in accounting estimates
The Fund does not need to explain any significant changes in accounting estimates during the reporting period. (Downloaded to D75 version)
